LIQT flags Nasdaq bid-price deficiency with January 2027 compliance deadline
LIQT is in focus after LiqTech International, Inc. received a deficiency notice from The Nasdaq Stock Market on July 21, 2026, citing failure to meet the $1.00 minimum bid price required for continued listing under Nasdaq Listing Rule 5550(a)(2). The stock's closing bid price ran below that threshold for 30 consecutive business days before the notice date. The next hard date on the calendar is January 19, 2027.
Key takeaways
- LiqTech International (LIQT) received a Nasdaq deficiency notice on July 21, 2026 for failing to meet the $1.00 minimum bid price required under Listing Rule 5550(a)(2).
- The stock's closing bid price stayed below $1.00 for 30 consecutive business days before the notice, which carries no immediate delisting action.
- LiqTech has an initial 180-calendar-day window, ending January 19, 2027, to regain compliance by closing at $1.00 or above for at least 10 consecutive business days.
- A second 180-day extension may be available if the company meets other Nasdaq Capital Market listing standards and submits written notice of its intent to cure the deficiency.
- As of the July 24, 2026 filing, LiqTech had not named a specific compliance mechanism and said it is monitoring its bid price and considering its options.
LIQT is in focus after LiqTech International, Inc. received a deficiency notice from The Nasdaq Stock Market on July 21, 2026, citing failure to meet the $1.00 minimum bid price required for continued listing under Nasdaq Listing Rule 5550(a)(2). The stock's closing bid price ran below that threshold for 30 consecutive business days before the notice date. The next hard date on the calendar is January 19, 2027.
What the 8-K discloses
The current report, signed by Chief Executive Officer Fei Chen and filed July 24, 2026, is clear on the immediate trading picture. Common stock remains listed on The Nasdaq Capital Market under the symbol LIQT. The deficiency notice itself carries no immediate delisting action.
That framing matters less than the compliance math. Under Nasdaq Listing Rule 5810(c)(3)(A), LiqTech has an initial 180-calendar-day window to fix the problem. Clearing the bar requires the closing bid price to reach $1.00 or above for a minimum of 10 consecutive business days before January 19, 2027.
The second-chance structure
A second 180-day extension is available if the first period expires without compliance, but the conditions tighten. LiqTech would need to meet the continued listing requirement for market value of publicly held shares and satisfy all other initial listing standards for The Nasdaq Capital Market, with the minimum bid price requirement as the sole exception. The company would also be required to submit written notice to Nasdaq stating its intention to cure the deficiency during the second compliance period.
Failing to qualify for the extension, or exhausting it without result, would trigger a formal delisting determination. An appeal to a Hearings Panel would be the company's remaining procedural option before removal from the exchange.
What to watch
LiqTech is incorporated in Nevada and operates out of Ballerup, Denmark. The filing states the company is monitoring its closing bid price and considering its options under the Nasdaq Listing Rules. No specific compliance mechanism appears in the filing as of July 24, 2026.
The next confirmable event on the tape: 10 consecutive business days at or above $1.00, or a separate public disclosure naming the company's chosen path to compliance.
Filed by the macro desk of MarketPR on July 25, 2026. Source: sec.gov. Indicative figures are not investment advice.